Ann: First AngelMed Guardian implants in Asia-Pacific, page-11

only 106m FP if i am reading the App 2a correctly.

A mc of 106m - not impossible at $1, as med tech plays go.
But will want to get some news headlines first. I reckon the Australian implants, is where you might see more coverage. On the earnings side, will take a gradual approach to building , and patient gravitating to an insurance policy. If you have had a heart attack, or at risk, getting alert early before damage worsens may save your life. These are being implanted via special early access permits, with new 7 year battery i think, and we are also waiting for next year, the FDA approval of this battery, so then they can ramp up in other countries i assume, all systems go at that point. So ideal time to position, before the newsflow starts to get louder attention.

But in terms of valuation, the market can pay ahead if it can see the commercial pathway adding gathering credibility. There are many in the med tech space, priced higher by the market, before any earnings are received, because of where the market thinks it is going over the forward metric.